[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350212-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350212-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","real-world-evidence-on-hospitalization-costs-of-pediatric-neoplasm-patients-in-china-patterns-trends-and-associated-factors","Real-World Evidence on Hospitalization Costs of Pediatric Neoplasm Patients in China - Patterns, Trends, and Associated Factors","","Real-world evidence on hospitalization costs for pediatric neoplasm patients in China is limited, particularly from longitudinal real-world studies. This retrospective multicenter cohort study (2017–2023) analyzed pediatric hospitalizations in Shanghai by linking two administrative databases, covering children ≤18 years with ICD-10-coded benign and malignant neoplasms and related complications. Costs were discounted to 2023 values, converted to US dollars, and modeled using descriptive statistics and generalized linear models to identify key socioeconomic, clinical, and hospital drivers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/real-world-evidence-on-hospitalization-costs-of-pediatric-neoplasm-patients-in-china-patterns-trends-and-associated-factors/350212/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/real-world-evidence-on-hospitalization-costs-of-pediatric-neoplasm-patients-in-china-patterns-trends-and-associated-factors/350212.png","ImageObject",300,407,{"name":42,"@type":43},"วิน","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What study design and data sources were used to analyze pediatric hospitalization costs?","Question",{"text":63,"@type":64},"The study used a retrospective multicenter cohort design (2017–2023) and analyzed pediatric hospitalization data in Shanghai by integrating two administrative databases.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did hospitalization costs for neoplasm patients change from 2017 to 2023?",{"text":68,"@type":64},"Total costs for neoplasm patients declined by 26.88% from 2017 to 2023, mainly driven by a 52.87% reduction in drug costs, while costs for nonneoplasm patients increased.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors were identified as significant drivers of hospitalization costs?",{"text":72,"@type":64},"Generalized linear model analysis identified sex, insurance type, pathology, surgical interventions, length of stay, and hospital characteristics as significant cost drivers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350212,1790937228,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","Cancer Medicine  \n|  RESEARCH ARTICLE  OPEN ACCESS \u003Cbr>Real-World Evidence on Hospitalization Costs of Pediatric Neoplasm Patients in China: Patterns, Trends, and Associated Factors From a Retrospective Cohort Study\u003Cbr>Peng Zhang1 | Bifan Zhu2 | Linan Wang2,3 \u003Cbr>1Shanghai University of Traditional Chinese Medicine, School of Nursing, Pudong District, Shanghai, China | 2Shanghai Health Development Research Center, Shanghai, China | 3Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China\u003Cbr>Correspondence: Linan Wang ([wanglinan@shdrc.org](wanglinan@shdrc.org))\u003Cbr>Received: 10 December 2024 | Revised: 22 May 2025 | Accepted: 1 December 2025 |  |\n| --- | --- |\n| ABSTRACT\u003Cbr>Background: In China, the incidence and burden of pediatric neoplasms have been increasing, contributing to escalating healthcare expenditures and productivity losses, with hospitalization costs constituting a major component of the economic burden. However, evidence on the full spectrum of neoplasm-related hospitalization costs for pediatric patients remains limited, particularly from real-world longitudinal studies.\u003Cbr>Methods: This retrospective multicenter cohort study (2017–2023) analyzed pediatric hospitalization data in Shanghai by integrating data from two administrative databases. The study included all children aged ≤18years hospitalized with ICD-10-coded benign and malignant neoplasms and related complications. Hospitalization costs were discounted to 2023 values, converted to US dollars, and analyzed using descriptive statistics and generalized linear models (GLMs) to identify influencing factors, including socioeconomic, clinical, and hospital-related variables.\u003Cbr>Results: Among 688,131 pediatric hospitalizations, 13,057 (1.91%) were for neoplasms. Neoplasm patients had significantly higher care intensity and hospitalization costs than nonneoplasm patients, with malignant neoplasms incurring the highest median costs. From 2017 to 2023, total costs for neoplasm patients declined by 26.88%, driven by a 52.87% reduction in drug costs, contrasting with rising costs for nonneoplasm patients. Leukemia was the most prevalent condition, while some rare but high-cost entities, such as secondary malignant neoplasms of the respiratory and digestive organs, were among the most expensive. GLM analysis identified sex, insurance type, pathology, surgical interventions, length of stay, and hospital characteristics as significant cost drivers.\u003Cbr>Conclusion: This study provides comprehensive evidence on hospitalization cost patterns, trends, and influencing factors for pediatric neoplasms. It highlights the need for enhanced insurance coverage, early diagnosis and treatment, and equitable resource allocation to reduce disparities. |  |\n| 1 | Background | Over 80% of childhood cancer cases and 90% of related deaths occur in low-and middle-income countries (LMIC) [3–5] . As the |\n| Childhood cancer is a significant cause of morbidity and mor- | largest and most populous LMIC, China has been undergoing a |\n| tality worldwide. It ranks as the second leading cause of non- | rapid epidemiological transition. The burden of childhood neo- |\n| communicable deaths among children globally [1], and accounts | plasm in China is continuously growing and remains the heavi- |\n| for 11.5 million global disability-adjusted life years (DALYs) [2] . | est [6] . The largest number of incident cases and DALYs of total |\n| Peng Zhang and Bifan Zhu arejoint as first authors. |  |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2026 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd. |  |\n\nCancer Medicine, 2026; 15:e71635 1 of 11  \n[https://doi.org/10.1002/cam4.71635](https://doi.org/10.1002/cam4.71635)  \nneoplasm of children, and the highest prevalence of childhood ca","cbCairxmcRnTHT3Q","https://ap.wps.com/l/cbCairxmcRnTHT3Q","pdf",642407,11,"English","# Background\n# Methods\n# Results\n# Conclusion\n## Cost trends and influencing factors","[{\"question\":\"What study design and data sources were used to analyze pediatric hospitalization costs?\",\"answer\":\"The study used a retrospective multicenter cohort design (2017–2023) and analyzed pediatric hospitalization data in Shanghai by integrating two administrative databases.\"},{\"question\":\"How did hospitalization costs for neoplasm patients change from 2017 to 2023?\",\"answer\":\"Total costs for neoplasm patients declined by 26.88% from 2017 to 2023, mainly driven by a 52.87% reduction in drug costs, while costs for nonneoplasm patients increased.\"},{\"question\":\"Which factors were identified as significant drivers of hospitalization costs?\",\"answer\":\"Generalized linear model analysis identified sex, insurance type, pathology, surgical interventions, length of stay, and hospital characteristics as significant cost drivers.\"}]","Real-World Evidence on Hospitalization Costs of Pediatric Neoplasm Patients in China - Patterns, Trends, and Associated Factors | PDF",1790087808,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d58708c9ab9472755cf49aa2554bc103.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4df332cc61a8b45508b0c88df85e1c98.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f03a18152ade0e8a97386c9b09682d7a.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b33c140797333526ad3e059767c1c10.webp",980,1287]